323990.KQ Gross Margin

The Gross Margin of Vaxcell Bio Therapeutics (323990.KQ) is 19.21%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

323990.KQ Gross Margin - Historical Value

Date	Value
2024-12-31	19.21%
2023-12-31	51.94%

323990.KQ Gross Margin - Peers Comparison

Ticker	Name	Value
042520.KQ	Hans Biomed Corp	63.78%
065660.KQ	Anterogen Co Ltd	37.91%
086820.KQ	Bio Solution Co Ltd	63.32%
185490.KQ	EyeGene Inc	34.50%
304840.KQ	PeopleBio Inc	36.22%
086890.KQ	Isu Abxis Co Ltd	71.93%
049960.KQ	Cell Biotech Co Ltd	72.25%
214450.KQ	PharmaResearch Co Ltd	71.76%
244460.KQ	OliPass Corp	36.65%
290650.KQ	L&C Bio Co Ltd	49.56%
011000.KS	Gene One Life Science Inc	-30.43%
083790.KQ	CrystalGenomics Invites Co Ltd	-7.16%
086900.KQ	Medy Tox Inc	60.81%
145020.KQ	Hugel Inc	76.98%
166480.KQ	Corestemchemon Inc	-3.89%
191420.KQ	Tego Science Inc	70.67%
084990.KQ	Helixmith Co Ltd	57.91%
138610.KQ	Nibec Co Ltd	51.65%
142760.KQ	BL Corp	29.36%
263050.KQ	Eutilex Co Ltd	6.56%
005690.KS	Pharmicell Co Ltd	32.89%
031390.KQ	Green Cross Cell Corp	39.84%
174900.KQ	AbClon Inc	46.02%
256840.KQ	BNC Korea Co Ltd	44.82%
228760.KQ	Genomictree Inc	-30.76%
048530.KQ	iNtRON Biotechnology Inc	58.23%
092040.KQ	Amicogen Inc	29.08%
153710.KQ	OptiPharm Co Ltd	24.94%